David Meyer - Aurora Spine Chief Legal Officer, VP and Secretary

ASG Stock  CAD 0.42  0.01  2.33%   

VP

Mr. David M. Meyer serves as Vice President, Chief Legal Officer, Secretary of the company.
Address 20 Holly Street, Toronto, ON, Canada, M4S 3B1
Phone760 424 2004
Webhttps://www.aurora-spine.com

David Meyer Latest Insider Activity

Tracking and analyzing the buying and selling activities of David Meyer against Aurora Spine stock is an integral part of due diligence when investing in Aurora Spine. David Meyer insider activity provides valuable insight into whether Aurora Spine is net buyers or sellers over its current business cycle. Note, Aurora Spine insiders must abide by specific rules, including filing SEC forms every time they buy or sell Aurora Spine'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Aurora Spine Management Efficiency

The company has return on total asset (ROA) of (0.025) % which means that it has lost $0.025 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1452) %, meaning that it generated substantial loss on money invested by shareholders. Aurora Spine's management efficiency ratios could be used to measure how well Aurora Spine manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2024. Return On Capital Employed is likely to drop to -0.05 in 2024. At this time, Aurora Spine's Other Current Assets are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.1 in 2024, whereas Non Current Assets Total are likely to drop slightly above 2.4 M in 2024.
Aurora Spine Corp has accumulated 3.65 M in total debt with debt to equity ratio (D/E) of 92.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Aurora Spine Corp has a current ratio of 2.42, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aurora Spine until it has trouble settling it off, either with new capital or with free cash flow. So, Aurora Spine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aurora Spine Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aurora to invest in growth at high rates of return. When we think about Aurora Spine's use of debt, we should always consider it together with cash and equity.
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and commercialization of interspinous fusion systems and devices in Canada. The company was incorporated in 2013 and is headquartered in Toronto, Canada. AURORA SPINE operates under Medical Devices classification in Canada and is traded on TSX Venture Exchange. Aurora Spine Corp (ASG) is traded on TSX Venture Exchange in Canada and employs 5 people. Aurora Spine is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Aurora Spine Corp Leadership Team

Elected by the shareholders, the Aurora Spine's board of directors comprises two types of representatives: Aurora Spine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurora. The board's role is to monitor Aurora Spine's management team and ensure that shareholders' interests are well served. Aurora Spine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurora Spine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Trent Northcutt, CEO and President and Director
David Meyer, Chief Legal Officer, VP and Secretary
Laszlo Garamszegi, CTO Founder
Chad Clouse, Chief Officer
Matthew Goldstone, Chief Officer

Aurora Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aurora Spine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aurora Stock Analysis

When running Aurora Spine's price analysis, check to measure Aurora Spine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurora Spine is operating at the current time. Most of Aurora Spine's value examination focuses on studying past and present price action to predict the probability of Aurora Spine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurora Spine's price. Additionally, you may evaluate how the addition of Aurora Spine to your portfolios can decrease your overall portfolio volatility.